Tirzepatide is the first dual-target therapy that activates both GIP and GLP-1 receptors, helping manage blood sugar levels while also supporting weight reduction—positioning it for potential use in t...
At BT’s India’s Most Sustainable Companies Summit 2025, Environment Minister calls for global equity in climate action as India meets its 2030 targets ahead of time.
As global shortages hit Ozempic and Wegovy, rivals like Eli Lilly gain ground, including in India’s growing market for obesity and lifestyle drugs
Novo Nordisk is making a strategic push into India's weight-loss market to secure its position ahead of competition from generics and rivals like Eli Lilly's Mounjaro
Adar Poonawalla-led Poonawalla Fincorp aims for primary infusion to support financial services growth
Hendrichs, MODIFI’s Chief Commercial Officer, highlighting the company’s focus on empowering SMEs, particularly in renewables and pharma, as part of its broader growth strategy
Adar Poonawalla-led Serum Institute of India was the poster child of the fight against Covid-19 with Covishield. it is now undergoing a transformation by leveraging to shore up its finances, which fel...
Shifting from volume to value, the company challenges India’s fee-for-service model with its managed care approach
Indian women are increasingly taking charge of their health and pharma majors are racing to meet their needs.
Healthcare firm eyes capacity growth in NCR, Mumbai, Bengaluru; diagnostics recovery underway.
Caste Census In 2027: Why India’s Next Headcount Is Sparking Political Storms
Why Assam Sinks Every Monsoon: The Unending Cycle Of Floods, Fear, And Forgotten Promises
The Day Democracy Died In China: Inside The Tiananmen Square Massacre Of 1989
Why Ukraine’s Drone Blitz Is Being Compared To Pearl Harbor: Strategy, Surprise & Shock
Agro-Terrorism Explained: How Biological Weapons Are Being Used To Attack Food Security
